Senate Resolution
S.Res. 477
A resolution designating the first full week in May as "Tardive Dyskinesia Awareness Week".
Primary Sponsor
Markwayne Mullin
R - OK
Cosponsors
1
Quick Stats
Policy Area
Summary
This resolution designates the first full week in May as Tardive Dyskinesia Awareness Week. An estimated 800,000 adults in the US live with this movement disorder caused by prolonged antipsychotic medication use, and approximately 60% remain undiagnosed.
Latest Action
Referred to the Committee on the Judiciary. (text: CR S7851-7852)
See this page through your district lens
Enter ZIP to personalize representatives and vote context.
Stay on top of this issue
Subscribe for weekly bill and representative updates.
Vote Prediction
A resolution designating the first full week in May as "Tardive Dyskinesia Awareness Week".
This resolution designates the first full week in May as Tardive Dyskinesia Awareness Week. An estimated 800,000 adults in the US live with this movement disorder caused by prolonged antipsychotic medication use, and approximately 60% remain undiagnosed.
Community Breakdown
Pass
0%
Fail
0%
0 predictions
This resolution designates the first full week in May as Tardive Dyskinesia Awareness Week. An estimated 800,000 adults in the US live with this movement disorder caused by prolonged antipsychotic medication use, and approximately 60% remain undiagnosed.
- Bill Number
- 477
- Introduced
- 10/30/2025
- Status
- Referred to the Committee on the Judiciary. (text: CR S7851-7852)
- Policy Area
- Health
Data from Congress.gov
Fact Sheet
- Title
- A resolution designating the first full week in May as "Tardive Dyskinesia Awareness Week".
- Bill Number
- 477
- Sponsor
- No sponsor
- Status
- Referred to the Committee on the Judiciary. (text: CR S7851-7852)
- Introduced
- 10/30/2025
- Summary
- This resolution designates the first full week in May as Tardive Dyskinesia Awareness Week. An estimated 800,000 adults in the US live with this movement disorder caused by prolonged antipsychotic medication use, and approximately 60% remain undiagnosed.
Data from Congress.gov
Public Opinions
Community submissions related to this bill.
No public opinions yet. Be the first to submit one for this bill.
Related Bills in Health
Empowering Patient Choice of Medical Care Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means
To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
Referred to the House Committee on Energy and Commerce.
Anti-Racism in Public Health Act of 2025
Referred to the House Committee on Energy and Commerce.
SOAR Act of 2025
Read twice and referred to the Committee on Finance.